Therapeutic Respiratory Devices Market Share, Growth, Trends | Report 2022-2030
The global therapeutic respiratory devices market was surpassed at USD 10.2 billion in 2021 and is expected to hit around USD 16.3 billion by 2030, growing at a CAGR of 5.35% from 2022 to 2030.
A growing geriatric population base, rapid technological advancements, and increasing prevalence of respiratory diseases are the key factors that are driving the market. The market is expected to grow due to rapid technological advancements in the healthcare sector. Nowadays, respiratory monitoring devices use software applications for the collection and analysis of data from ventilators equipped with the health system.
The tools in the software application improve patient monitoring through the measurement of parameters such as process and clinical variation in the ventilator therapy. The global increase in the cases of respiratory diseases is one of the major factors that are driving the market for therapeutic respiratory devices. According to the European Academy of Allergy and Clinical Immunology (EAACI) Global Atlas of Asthma 2021, more than 350 million patients around the world are suffering from asthma.
Moreover, waveform capnography is a technical advancement used in monitoring carbon dioxide levels. New product launch such as automated and stand-alone pressure controls for mechanical ventilators boosts the growth of the market. These pressure controllers enable a reduction in the risk of tracheal injuries and Ventilator-associated Pneumonia (VAP). For instance, in November 2021, Fischer and Paykel launched F&P Visairo, a hospital under-nose mask for noninvasive ventilation, in the United States. F&P Visairo is a new high-performance under-nose hospital mask with dynamic support technology. The company also offers a humidifier with an integrated flow generator, which delivers high flows of air mixture to patients spontaneously breathing. Such factors are bolstering the growth of the market.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 10.2 billion |
| Revenue Forecast by 2030 | USD 16.3 billion |
| Growth rate from 2022 to 2030 | CAGR of 5.35% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Product type, technology, filter, region |
| Companies Covered |
BD; General Electric Company; Chart industries; Koninklijke Philips N.V.; Compumedics Limited.; ICU Medical, Inc.; CAIRE Inc.; Invacare Corporation; Mindray |
Product Type Insights
The positive airway pressure devices segment dominated the market and accounted for a revenue share of more than 58.0% in 2021 and is anticipated to register the fastest growth in the forecast period. This can be attributed to increasing incidences of obstructive sleep apnea that are responsible for the growth of this segment. This is attributed to lifestyle-associated factors such as obesity, alcohol consumption, smoking, and conditions such as craniofacial abnormalities. According to the National Library of Medicine, in 2020, 26% of the total population in the U.S. is reported to have obstructive sleep apnea syndrome. Increasing use of these devices by the geriatric patient base is also responsible for the growth of the market.
Technology Insights
The HEPA filter technology segment dominated the market in 2021 and accounted for a revenue share of more than 30.0%. High efficiency particulate air filters are employed for particle removal and retention in different therapeutic respiratory devices. As per the CDC guidelines, the therapeutic devices must be equipped with HEPA filtration technology for air filtration. The prevalence of respiratory diseases and their transmission are among the factors that drive the demand for HEPA filter technology. As per the U.S. States Department of Energy (DOE), HEPA filters remove 99.97% of all particles that are greater than 0.3 microns. The technological advancements in the segment are expected to produce a positive impact on the market in the next seven years. These advancements include washable HEPA filters and HEPA 4 technology, which has the Minimum Efficiency Reporting Value (MERV) rating of the filter. It is used to rate the ability of air filters to remove particulate matter from the air.
Filters Insights
The humidifier filters segment is anticipated to register the fastest CAGR of 13.0% during the forecast period due to their rising demand for various therapeutic applications. The rising demand for humidifiers in hospitals, schools, homes, and healthcare entities is expected to boost the growth of the humidifier filters segment as filters are needed to prevent the growth of mold, mildew, fungi, and bacteria in the circulating air. Moreover, the increased prevalence of airborne infections such as tuberculosis leads to a rise in demand for filters in humidifiers, thus affecting the segment growth positively.
The ventilator filter segment is also expected to witness significant growth over the projected period, as it plays a vital role in protecting the safety of patients on mechanical ventilation and reducing the risk of cross-contamination. Furthermore, high demand during the COVID-19 pandemic also contributed to its market size in 2021. Some of the players in this segment include Medtronic and Omnia Health, among others.
Regional Insights
North America dominated the market and accounted for a revenue share of 51.8% in 2021 owing to the presence of a large geriatric population base and the rising prevalence of chronic respiratory diseases. Furthermore, the major share of the market in North America is due to the availability of reimbursement in U.S. healthcare centers accounts, increasing healthcare awareness, improvement in healthcare infrastructure, increased number of outpatient surgeries, and economic growth favored by broadening insurance coverage.
The government health plans such as Medicaid and Medicare aided by CMS also drive the growth of the therapeutic respiratory devices market in this region. These health plans cover respiratory therapy using respiratory devices such as Continuous Positive Airway Pressure devices for the treatment of COPD and Obstructive Sleep Apnea (OSA). The increasing number of hospitals in North America and rising government funding to the hospitals is accelerating market growth. According to an article published by American Hospital Association, number of hospitals has raised from 6,146 in 2018 to 6,210 in 2019 in the U.S. Technologically advanced devices are being used extensively in hospitals to provide better treatment to patients.
In Asia Pacific, the market is expected to exhibit the fastest growth during the forecast period owing to factors such as the rising prevalence of asthma in adults as well as children and technological advancements. According to statistics released by the Global Initiative for Asthma, it is expected that there will be an increase of an additional 100 million persons with asthma by 2025. Moreover, the increasing need for home healthcare institutions is also a high impact rendering driver of this market in this region. Furthermore, rising disposable incomes and lifestyle-associated changes are also responsible for the significant growth rate in this region over the forecast period.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1.Research Objective
1.2.Scope of the Study
1.3.Definition
Chapter 2. Research Methodology
2.1.Research Approach
2.2.Data Sources
2.3.Assumptions & Limitations
Chapter 3. Executive Summary
3.1.Market Snapshot
Chapter 4. Market Variables and Scope
4.1.Introduction
4.2.Market Classification and Scope
4.3.Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Filters Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Therapeutic Respiratory Devices Market
5.1.COVID-19 Landscape: Therapeutic Respiratory Devices Industry Impact
5.2.COVID 19 - Impact Assessment for the Industry
5.3.COVID 19 Impact: Global Major Government Policy
5.4.Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1.Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2.Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Therapeutic Respiratory Devices Market, By Product
8.1.Therapeutic Respiratory Devices Market, by Product Type, 2022-2030
8.1.1. Nebulizers
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Humidifiers
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Oxygen Concentrators
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Positive Airway Pressure Devices
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Ventilators
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Capnographs
8.1.6.1. Market Revenue and Forecast (2017-2030)
8.1.7. Gas Analyzers
8.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Therapeutic Respiratory Devices Market, By Technology
9.1.Therapeutic Respiratory Devices Market, by Technology, 2022-2030
9.1.1. Electrostatic Filtration
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. HEPA Filter Technology
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Hollow Fiber Filtration
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Microsphere Separation
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10.Global Therapeutic Respiratory Devices Market, By Filters
10.1.Therapeutic Respiratory Devices Market, by Filters, 2022-2030
10.1.1.Nebulizer filters
10.1.1.1.Market Revenue and Forecast (2017-2030)
10.1.2.Humidifier Filters
10.1.2.1.Market Revenue and Forecast (2017-2030)
10.1.3.Positive Airway Pressure Devices Filter
10.1.3.1.Market Revenue and Forecast (2017-2030)
10.1.4.Oxygen concentrator filters
10.1.4.1.Market Revenue and Forecast (2017-2030)
10.1.5.Ventilator filters
10.1.5.1.Market Revenue and Forecast (2017-2030)
Chapter 11.Global Therapeutic Respiratory Devices Market, Regional Estimates and Trend Forecast
11.1.North America
11.1.1.Market Revenue and Forecast, by Product (2017-2030)
11.1.2.Market Revenue and Forecast, by Technology (2017-2030)
11.1.3.Market Revenue and Forecast, by Filters (2017-2030)
11.1.4.U.S.
11.1.4.1.Market Revenue and Forecast, by Product (2017-2030)
11.1.4.2.Market Revenue and Forecast, by Technology (2017-2030)
11.1.4.3.Market Revenue and Forecast, by Filters (2017-2030)
11.1.5.Rest of North America
11.1.5.1.Market Revenue and Forecast, by Product (2017-2030)
11.1.5.2.Market Revenue and Forecast, by Technology (2017-2030)
11.1.5.3.Market Revenue and Forecast, by Filters (2017-2030)
11.2.Europe
11.2.1.Market Revenue and Forecast, by Product (2017-2030)
11.2.2.Market Revenue and Forecast, by Technology (2017-2030)
11.2.3.Market Revenue and Forecast, by Filters (2017-2030)
11.2.4.UK
11.2.4.1.Market Revenue and Forecast, by Product (2017-2030)
11.2.4.2.Market Revenue and Forecast, by Technology (2017-2030)
11.2.4.3.Market Revenue and Forecast, by Filters (2017-2030)
11.2.5.Germany
11.2.5.1.Market Revenue and Forecast, by Product (2017-2030)
11.2.5.2.Market Revenue and Forecast, by Technology (2017-2030)
11.2.5.3.Market Revenue and Forecast, by Filters (2017-2030)
11.2.6.France
11.2.6.1.Market Revenue and Forecast, by Product (2017-2030)
11.2.6.2.Market Revenue and Forecast, by Technology (2017-2030)
11.2.6.3.Market Revenue and Forecast, by Filters (2017-2030)
11.2.7.Rest of Europe
11.2.7.1.Market Revenue and Forecast, by Product (2017-2030)
11.2.7.2.Market Revenue and Forecast, by Technology (2017-2030)
11.2.7.3.Market Revenue and Forecast, by Filters (2017-2030)
11.3.APAC
11.3.1.Market Revenue and Forecast, by Product (2017-2030)
11.3.2.Market Revenue and Forecast, by Technology (2017-2030)
11.3.3.Market Revenue and Forecast, by Filters (2017-2030)
11.3.4.India
11.3.4.1.Market Revenue and Forecast, by Product (2017-2030)
11.3.4.2.Market Revenue and Forecast, by Technology (2017-2030)
11.3.4.3.Market Revenue and Forecast, by Filters (2017-2030)
11.3.5.China
11.3.5.1.Market Revenue and Forecast, by Product (2017-2030)
11.3.5.2.Market Revenue and Forecast, by Technology (2017-2030)
11.3.5.3.Market Revenue and Forecast, by Filters (2017-2030)
11.3.6.Japan
11.3.6.1.Market Revenue and Forecast, by Product (2017-2030)
11.3.6.2.Market Revenue and Forecast, by Technology (2017-2030)
11.3.6.3.Market Revenue and Forecast, by Filters (2017-2030)
11.3.7.Rest of APAC
11.3.7.1.Market Revenue and Forecast, by Product (2017-2030)
11.3.7.2.Market Revenue and Forecast, by Technology (2017-2030)
11.3.7.3.Market Revenue and Forecast, by Filters (2017-2030)
11.4.MEA
11.4.1.Market Revenue and Forecast, by Product (2017-2030)
11.4.2.Market Revenue and Forecast, by Technology (2017-2030)
11.4.3.Market Revenue and Forecast, by Filters (2017-2030)
11.4.4.GCC
11.4.4.1.Market Revenue and Forecast, by Product (2017-2030)
11.4.4.2.Market Revenue and Forecast, by Technology (2017-2030)
11.4.4.3.Market Revenue and Forecast, by Filters (2017-2030)
11.4.5.North Africa
11.4.5.1.Market Revenue and Forecast, by Product (2017-2030)
11.4.5.2.Market Revenue and Forecast, by Technology (2017-2030)
11.4.5.3.Market Revenue and Forecast, by Filters (2017-2030)
11.4.6.South Africa
11.4.6.1.Market Revenue and Forecast, by Product (2017-2030)
11.4.6.2.Market Revenue and Forecast, by Technology (2017-2030)
11.4.6.3.Market Revenue and Forecast, by Filters (2017-2030)
11.4.7.Rest of MEA
11.4.7.1.Market Revenue and Forecast, by Product (2017-2030)
11.4.7.2.Market Revenue and Forecast, by Technology (2017-2030)
11.4.7.3.Market Revenue and Forecast, by Filters (2017-2030)
11.5.Latin America
11.5.1.Market Revenue and Forecast, by Product (2017-2030)
11.5.2.Market Revenue and Forecast, by Technology (2017-2030)
11.5.3.Market Revenue and Forecast, by Filters (2017-2030)
11.5.4.Brazil
11.5.4.1.Market Revenue and Forecast, by Product (2017-2030)
11.5.4.2.Market Revenue and Forecast, by Technology (2017-2030)
11.5.4.3.Market Revenue and Forecast, by Filters (2017-2030)
11.5.5.Rest of LATAM
11.5.5.1.Market Revenue and Forecast, by Product (2017-2030)
11.5.5.2.Market Revenue and Forecast, by Technology (2017-2030)
11.5.5.3.Market Revenue and Forecast, by Filters (2017-2030)
Chapter 12.Company Profiles
12.1.BD
12.1.1.Company Overview
12.1.2.Product Offerings
12.1.3.Financial Performance
12.1.4.Recent Initiatives
12.2.General Electric Company
12.2.1.Company Overview
12.2.2.Product Offerings
12.2.3.Financial Performance
12.2.4.Recent Initiatives
12.3.Chart industries
12.3.1.Company Overview
12.3.2.Product Offerings
12.3.3.Financial Performance
12.3.4.Recent Initiatives
12.4.Koninklijke Philips N.V
12.4.1.Company Overview
12.4.2.Product Offerings
12.4.3.Financial Performance
12.4.4.Recent Initiatives
12.5.Compumedics Limited
12.5.1.Company Overview
12.5.2.Product Offerings
12.5.3.Financial Performance
12.5.4.Recent Initiatives
12.6.ICU Medical, Inc.
12.6.1.Company Overview
12.6.2.Product Offerings
12.6.3.Financial Performance
12.6.4.Recent Initiatives
12.7.Invacare Corporation
12.7.1.Company Overview
12.7.2.Product Offerings
12.7.3.Financial Performance
12.7.4.Recent Initiatives
Chapter 13.Research Methodology
13.1.Primary Research
13.2.Secondary Research
13.3.Assumptions
Chapter 14.Appendix
14.1.About Us
14.2.Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers